FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40559411000001103: Xaqua 5mg tablets (Renascience Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Apr 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2239751000001110 Xaqua 5mg tablets (Renascience Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2239761000001113 Xaqua 5mg tablets (Renascience Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xaqua 5mg tablets (Renascience Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) Is a Product containing precisely metolazone 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) Is a Xaqua true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) Has specific active ingredient Metolazone true Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Xaqua 5mg tablets (Renascience Pharma Ltd) 20 tablet Has AMP True Xaqua 5mg tablets (Renascience Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start